Tier 3 — preclinical

Long-lived mammals contain more phosphorylation sites in the SIRT6 C-terminus that enhance PARP1 interaction and resistance to oxidative stress

Jonathan Gigas, Michael E Meadow, Jing Guo, Catherine Lan, Eric Hillpot, John C Martinez, Gregory Tombline, Philip Bellomio, Valeria Rivera-Almodóvar, Kevin A Welle, Kyle Swovick, Jennifer R Hryhorenko, Julia Ablaeva, Sina Ghaemmaghami, Andrei Seluanov, Vera Gorbunova
GeroScience 2026 Online ahead of print

Bibliography

PubMed
PMID 42417966
Funding
NIH/NIA grants AG047200 and AG027237.
Competing interests
Vera Gorbunova is a scientific advisory board member for DoNotAge, Genflow Bio, Elysium and WndrHealth. Other authors declared no competing interests.

Study snapshot

DesignComparative proteomics across mammalian species plus biochemical, in silico and human fibroblast mutation experiments.
ModelSIRT6 proteins across mammalian species; human fibroblasts carrying phospho-null or phospho-mimetic SIRT6 T294 variants.
SampleMultiple mammalian species and cell experiments; exact sample counts vary by experiment.
InterventionComparative SIRT6 phosphorylation profiling and T294A/T294E mutagenesis.
DurationExperimental; not a longitudinal treatment study.
EndpointsSIRT6 C-terminal phosphorylation; Maximum species lifespan correlation; PARP1 interaction; Oxidative-stress survival

What the study showed, in plain terms

Long-lived mammalian species carry and use more phosphorylation sites in the SIRT6 C-terminus. Hyperphosphorylated SIRT6 interacted more strongly with PARP1, and mimicking phosphorylation at T294 improved oxidative-stress resistance in human fibroblasts.

Key findings

SIRT6 C-terminal phosphosite abundance and use correlated with maximum lifespan across mammals. Hyperphosphorylation strengthened PARP1 interaction; T294A reduced and T294E improved survival after oxidative stress.

What this study can and cannot tell us

Comparative and cellular evidence cannot establish that deliberately increasing SIRT6 phosphorylation extends lifespan in humans. The work also includes an author with disclosed advisory relationships to longevity companies.

Citation network

Articles citing this research paper

5 articles

Biohack Blueprint analyses that reference this study in their evidence base.

Editorial review

Reviewed by the Biohack Blueprint research team

Last verified